iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on January 25, 2023
LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace...
Month: January 2023
Editas Medicine and Shoreline Biosciences Enter into Definitive Agreement for Shoreline to Acquire Editas’ iNK Cell Franchise and Related Gene Editing Technologies
Shoreline to obtain an exclusive license to SLEEK knock-in technology for iPSC-derived NK cells, an exclusive license to SLEEK for...
XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial
Safe and Effective Dosing of XORLO™CALGARY, Alberta, Jan. 19, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”)...
Alpine Beer Launches INFINITE HAZE Hazy IPA
New Hazy IPA Adds Depth to Year-Round Lineup as Alpine Expands Distribution into Florida Alpine Beer Company's new INFINITE HAZE...
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
-- Board Refreshment Process Has Been Comprehensive, Independent and Transparent; Sarissa’s Candidates Are Not Qualified Versus Recently Appointed Board Members...
InvestmentPitch Media Video Discusses FSD Pharma’s Submission of its Clinical Trial Application for Planned Phase-1 Trial for Lucid-MS, a Candidate for Treatment of MS
VANCOUVER, British Columbia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biopharmaceutical company dedicated to...
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA
LONDON and HONG KONG, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and...
Finnish Wellbeing Services Counties continue to choose Aino for Employee Sustainability
Another Finnish wellbeing services county has chosen Aino’s SaaS solution. The agreement contains a total of approximately 7 400 employees. Implementation is...
Autorisation de mise sur le marché françaises de IOPIDINE® 1 % (Apraclonidine) transférée à Essential Pharma en adéquation avec les besoins médicaux et la stratégie d’expansion de l’entreprise
Autorisation de mise sur le marché françaises de IOPIDINE® 1 % (Apraclonidine) transférée à Essential Pharma en adéquation avec les...
Castellum, Inc. Announces Signing of Non-Binding LOI for East Coast Government Contractor
Castellum, Inc. Announces Signing of Non-Binding LOI for East Coast Government Contractor Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare,...
Salt Dental Collective Appoints Dylan Bates as New CEO
Dylan Bates, Chief Executive Officer Salt Dental Collective announced that Dylan Bates has been appointed as the new Chief Executive...
BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT™ Combination in Advanced Metastatic Breast Cancer
BriaCell has received agreement and positive feedback from its End of Phase II meeting with the FDA for lead clinical...
Evoke Pharma Announces Acceptance of an Abstract at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2023
Real-world study compares diabetic gastroparesis patient utilization of healthcare resources before and after initiation of GIMOTISOLANA BEACH, Calif., Jan. 18,...
PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome
TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader...
ORYZON Announces First Patient In in NET, a Collaborative Phase II Basket Study With Iadademstat in R/R Patients With Neuroendocrine Carcinomas
Collaborative study with Fox Chase Cancer Center Trial will assess the safety and efficacy of iadademstat in pulmonary and extrapulmonary...
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
Live video webcast on Thursday, January 19th at 12:00 PM ETDURHAM, N.C., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Novan, Inc....
SAB Biotherapeutics Receives an Additional $8.2 Million in Closeout of DoD Contract
SIOUX FALLS, S.D., Jan. 18, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel...
Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development
Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge Bio co-founder, becomes...
IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
Reports preliminary fourth quarter 2022 revenue of $14.9 millionAnnounces full-year and first-quarter 2023 financial guidanceWINTER SPRINGS, Fla., Jan. 18, 2023...
Pasithea Therapeutics Signs CMC Development and Manufacturing Agreement for the Production of PAS-004
-- Plans to Initiate a Phase 1 Clinical Trial in the U.S. for Neurofibromatosis Type 1 (NF1) in 2H 2023...